Comparison of SGLT2 inhibitors with DPP-4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus

Although sodium-glucose cotransporter 2 inhibitors (SGLT2i) have demonstrated cardiovascular benefits in patients with type 2 diabetes mellitus, real-world evidence regarding their benefits to diabetic patient...

Source: Cardiovascular Diabetology - July 22, 2023 Category: Cardiology Authors: Young Sang Lyu, Seok Oh, Jin Hwa Kim, Sang Yong Kim and Myung Ho Jeong Tags: Research Source Type: research